Model-based estimation of the impact on rotavirus disease of RV3-BB vaccine administered in a neonatal or infant schedule

Author:

Geard Nicholas1ORCID,Bradhurst Richard2,Tellioglu Nefel1,Oktaria Vicka34,McVernon Jodie567,Handley Amanda78,Bines Julie E.7910

Affiliation:

1. School of Computing and Information Systems, The University of Melbourne, Parkville, Australia

2. Centre of Excellence for Biosecurity Risk Analysis, School of BioSciences, The University of Melbourne, Parkville, Australia

3. Department of Biostatistics, Epidemiology, and Population Health, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia

4. Center for Child Health – Pediatric Research Office, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia

5. Department of Infectious Diseases and Victorian Infectious Diseases Reference Laboratory Epidemiology Unit, The Peter Doherty Institute for Infection and Immunity, The Royal Melbourne Hospital and The University of Melbourne, Parkville, Australia

6. Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Australia

7. Murdoch Children’s Research Institute, Parkville, Australia

8. Medicines Development for Global Health, Southbank, Australia

9. Department of Gastroenterology and Clinical Nutrition, Royal Children’s Hospital, Parkville, Australia

10. Department of Paediatrics, The University of Melbourne, Parkville, Australia

Funder

Victorian Government’s Operational Infrastructure Support Program

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference36 articles.

1. Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 Years

2. International Vaccine Access Center. Viewhub report: global vaccine introduction and implementation. Baltimore, MD: Johns Hopkins Bloomberg School of Public Health; 2021. https://view-hub.org/sites/default/files/2021-11/VIEW-hub_Report_Sept2021.pdf

3. Understanding Reduced Rotavirus Vaccine Efficacy in Low Socio-Economic Settings

4. Rotavirus immunization: Global coverage and local barriers for implementation

5. Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3